View in Browser

Upcoming Events

Jan.

16

Pharmaceutical Sciences Public Seminar with Suzann Duan, PhD

Hedgehog signaling drives neural plasticity and oncogenic reprogramming in gastroenteropancreatic neuroendocrine tumors

12 - 1 PM

COHS 1020

Questions? Contact Arine Dekermenjian.

Jan.

24

Moving Toward an Understanding of the Health Consequences of Socioeconomic Disadvantage in Childhood

Gregory Miller, PhD (Northwestern) | Hosted by UCI Public Health

4 - 5 PM

COHS 2110 or Zoom

Register Here

Jan.

25

Health Disparities: A Psychosocial Perspective

Edith Chen, PhD (Northwestern) | Hosted by UCI Public Health

8:30 - 9:30 AM

COHS 2110 or Zoom

Register Here

Jan.

25

Physician Scientist Collective: Distinguished Speaker Series featuring Eric Vilain, MD, PhD

Translational research leadership in the global context: it's all about sharing

4 - 5 PM

Sprague Hall 105

Register Here

Jan.

30

UC Cancer Consortium Molecular Tumor Board

8 - 9 AM

Zoom

Referring physicians may submit active patient cases here

Register for the Session

Feb.

7

Research in Progress Seminar with Rishikesh Chavan, MD

Role of Regulatory T cells and its Clinical Applications in Cancer Immunotherapy, Stem Cell Transplant and Chimeric Antigen Receptor T (CAR-T) cell therapies and other Autoimmune conditions

12 - 1 PM

Zoom

Request a Calendar Invite or Join via Zoom

Feb.

21

Allen and Lee-Hwa Chao Lectureship in Cancer Research

Honoree: John D. Carpten, PhD



Feb. 21 | 5 PM (Reception), 6 PM (Lecture) | Community Lecture

The Beckman Center

Closing the Gaps to Achieve Cancer Health Equity: Factors Influencing Cancer Disparities

Register Here


Feb. 22 | 10 AM (Lecture) with Lunch to Follow | Scientific Lecture

Thorp Conf. Center, Gross Hall, 4th Floor

The Impact of Population and Tumor Heterogeneity in Cancer Health Disparities

Register Here

Belonging, Equity and Empowerment (BEE) Scene

Learning about each other is one way to cultivate an inclusive environment where everyone feels empowered to contribute and succeed. The Beyond Cancer Spotlight Series showcases the unique stories of our team members beyond their roles at the CFCCC. Learn more.

Beyond Cancer Spotlight: Claudia Benavente


Claudia Benavente, PhD (she/her), Associate Professor, School of Pharmacy and Pharmaceutical Sciences and recently appointed Deputy Associate Director, CRTEC, shares her journey from growing up in Ecuador to her current career and the sole reason you will never catch her running.

Learn More About Claudia

Announcements

Dr. Farshid Dayyani winner of the "2023 Pittsburgh Cancer Consortium Pewter Wheel Barrel Award"


This award from UPMC Hillman Cancer Center is in recognition of outstanding achievement in enrolling the most participants onto NCI sponsored early phase clinical trials. With a total of 5 out of 51 accruals in 2022, Dr. Dayyani demonstrated a clear commitment to advancing cancer research and improving patient care.


The top 3 accruing MDs from this year were from the CFCCC, including Drs. Jennifer Valerin and Nataliya Mar. Congrats to all!

Cancer Research Training & Education Opportunity: Cancer Clinical Trial Bootcamp


The CFCCC is accepting applications for the Cancer Clinical Trial Bootcamp – a 16-week program that guides clinical faculty and fellows in systematically designing and writing cancer-related investigator-initiated clinical trial protocols, with the goal of submitting a written protocol by the program's conclusion. We invite you to learn more about the program and eligibility requirements. 

Submit Your Application by Jan. 16, 2024

Advanced Workshop on Research Skills in Oncology


Wednesday, April 10 - Friday, April 12, 2024 | Virtual Workshop


A successful research career requires competencies in managing individuals as a leader, mentor, and collaborator. Additionally, sustaining a career in research demands the ability to manage the stress, disappointment, and competing priorities that are part of even the most successful careers. This NCI-funded intensive 3-day virtual workshop is designed to provide early-career principal investigators a foundation in these critical skills within a short period of time. 


Early-career principal investigators in all types of oncology research with research grants with at least $100,000 in total direct costs are eligible to apply. Researchers from under-represented racial and ethnic minority groups, women, and individuals who identify as sexual and gender minorities are particularly encouraged to apply. The workshop is supported by NCI R25 246746 and there is no tuition fee.

Submit Your Application by Jan. 15, 2024

The Biobehavioral Shared Resource (BBSR) Consultation & Comprehensive Project Request is Now Live


The BBSR is excited to discuss your project’s study design and needs, as well as see how our new menu of services can best support your project goals.


During our “Consultation Meeting” we’ll learn more about your project and how the BBSR can support your team. 


Questions? Contact Jose Lechuga, BBSR Core Manager.

Ready to Schedule? Complete "Consultation Request" on iLab 

Biostatistics Shared Resource - In-person Walk-in or Zoom Consultations Available


Informal statistical in-person walk-in or via Zoom consultations are available to discuss your study design and statistical needs. 


With Wen-pin Chen, MS, Senior Statistician & Manager for BSR:


With Thomas H. Taylor, PhD, Principal Statistician for BSR:

  • Every Wednesday from 2:00 - 3:00 PM via Zoom | No pre-booking necessary, drop in here
 

Funding Opportunities

For a curated list of internal, federal and foundation funding opportunities, please refer to CFCCC's Funding Opportunities webpage. Highlighted funding opportunities are listed below.


UCI & UC FUNDING OPPORTUNITIES


UCI CFCCC: A1 Bridge

Up to $20,000 in bridge funding to investigators who have received scores on NIH grant applications (i.e., not triaged) that have missed the funding pay line and will be resubmitted. Applications: Due on a rolling basis

Learn More and Apply >>


UC Cancer Research Coordinating Committee (CRCC) Faculty Seed Grants

Up to $85,000 for 2024-25 award year

CRCC funds support meritorious research spanning all areas from basic research to applied clinical and community-based research in any field relevant to cancer. Eligible PIs must be members of the Academic Senate at one of the ten UC campuses. 

LOI: Jan. 25, 2024 (12 PM PT)

Learn More and Apply >>

FOUNDATION FUNDING OPPORTUNITIES



V Foundation Women Scientist Innovation Award

Focus Area: Adult cancer research (exclusions: epidemiology, behavioral science, health services)

V-Scholar ($600K/3 years)

Translational Grant ($800K/4 years)

Applications: Jan. 19, 2024

Learn More and Apply >>

One candidate will be selected.


Melanoma Research Foundation

Resident/Fellow Research Grants - Applications: Jan. 19, 2024

Learn More and Apply >>

OTHER NON-FEDERAL FUNDING OPPORTUNITIES


2024 Mark Foundation Endeavor Awards (Team Research)

Focus: Basic, translational, clinical

$3M/3 years

LOI: March 12, 2024

Learn More and Apply >>

FEDERAL FUNDING OPPORTUNITIES


NCI Administrative Supplements for Cancer Disparity Collaborative Research

Focus: cancer health disparities research

Up to $510K over 24 months

Requires a partnership or collaboration between: an NCI-funded PI not involved in CHD (who serves as contact PI for the application), and a CHD researcher with a demonstrated record of expertise

Application: Jan. 23, 2024

Learn More and Apply >>


CDMRP Anticipated Funding Opportunities for 2024

Breast Cancer Research Program | Pre-Announcement

Multiple awards: Breakthrough Award, Era of Hope Scholar Award, Clinical Research Extension Award, Transformative Breast Cancer Consortium Award, Transformative Breast Cancer Consortium Development Award

Learn More >>


Ovarian Cancer Research Program | Pre-Announcement

Multiple awards: Pilot Award, Investigator-Initiated Research Award, Clinical Trial Award, Clinical Trial Translational Endpoints Award (new), Ovarian Cancer Academy Leadership Award (new), Ovarian Cancer Academy Early-Career-Investigator Award (new), and Ovarian Cancer Clinical Trial Academy Earl-Career Investigator Award (new)

Learn More >>

 

Newsroom

Anti-Cancer Challenge participants at finish line

The 2023 UCI Anti-Cancer Challenge raises $1 million for critical cancer research


A record 3,800 participants who turned out for the seventh annual UCI Anti-Cancer Challenge raised more than $1 million to support cancer research at the CFCCC and CHOC.



Read More >>

Questions? Contact us at cfcccadmin@hs.uci.edu